Jean Jacques Bienaime - Oct 4, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Oct 4, 2023
Transactions value $
$856
Form type
4
Date filed
12/12/2023, 07:55 PM
Previous filing
Aug 9, 2023
Next filing
Nov 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Small acquisition under Rule 16a-6 $856 +10 +0% $85.57 423K Oct 4, 2023 Direct F1
transaction BMRN Common Stock Award $0 +2.37K +0.56% $0.00 425K Dec 1, 2023 Direct F2
holding BMRN Common Stock 247K Oct 4, 2023 Shares held by Jean-Jacques Bienaime Family Trust
holding BMRN Common Stock 100 Oct 4, 2023 Shares held as UTMA custodian for child 1
holding BMRN Common Stock 100 Oct 4, 2023 Shares held as UTMA custodian for child 2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's sale of shares at a price of $99.56 on April 10, 2023. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
F2 Restricted stock units granted on December 1, 2023. Price not applicable.